What does the Triple Marker Test include?
Metropolis Healthcare measures AFP, hCG, and uE3 levels to assess fetal risk factors in the second trimester.
How does Metropolis Healthcare perform this test?
The test is conducted using high-precision serum analyzers to ensure reliable prenatal risk assessment.
Who should take the Triple Marker Test?
Pregnant women between 15–20 weeks may undergo this screening at Metropolis Healthcare for early fetal health evaluation.
Why is this test important during pregnancy?
It helps identify potential chromosomal conditions or developmental concerns with accurate analysis from Metropolis Healthcare.
What sample is required for the test?
A blood sample (serum) is collected at Metropolis Healthcare for evaluating the three key markers.
Do I need any special preparation before the test?
No special preparation is needed; Metropolis Healthcare ensures a smooth and quick sample collection process.
Can this test confirm abnormalities?
No, it is a screening test; Metropolis Healthcare may recommend diagnostic follow-up if results indicate elevated risk.
How soon will I receive my report?
Metropolis Healthcare provides timely results following standard prenatal screening turnaround times.